This is filed to report the atrial septal defect requiring intervention and thrombus.It was reported that on (b)(6) 2022, a mitraclip procedure was performed for a degenerative mitral regurgitation (mr) grade 4.One mitraclip was successfully implanted reducing the mr to a grade of 1-2.While removing the steerable guide catheter (sgc) from the patient, a clot in the right atrium was noticed.No treatment was provided and the physician does not think this was because of the device or procedure.In addition, the atrial septal defect (asd) was closed with a percutaneous device with no issues reported.There was no clinically significant delay in the procedure and no adverse patient sequelae.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the cause of the reported thrombus was unable to be determined.The cause of the reported perforation was unable to be determined.The reported patient effect of perforation and thrombus as listed in the mitraclip system instructions for use are known possible complications associated with mitraclip procedures.The reported unexpected medical intervention was the result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|